The claim of disease-modifying therapy also arises when discussing agents that alter the course of disease complications, such as cardiovascular, renal, and hepatic diseases in people with type 2 ...

Specialist in diabetes research Professor Kathleen Gillespie describes the under-recognised incidence of type 1 diabetes ...

Diabetes is a chronic condition that occurs when the body loses its ability to keep the level of sugar in the blood under ...

The division contributes to medical education in the community through Internal Medicine Grand Rounds, invited symposia, diabetes and endocrinology symposia. Clinical rotations are divided into ...

In conclusion, the current evidence is not sufficient to argue for a change in diabetes treatment with either insulin glargine or metformin. Clinical practice cannot be influenced by evidence ...

China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...

The Saint Louis University Division of Endocrinology, Diabetes and Metabolism provides comprehensive patient care services ... M.D. The long-standing tradition of research and clinical excellence ...

ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management ...

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

Following peer review, it will be launched via livestream and published in The Lancet Diabetes & Endocrinology in mid-January 2025 ... The new paper will propose a two-part clinical approach: First, ...

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function, allowing them to better manage their disease and possibly discontinue medication, according to ...